ArticleTheranostics2026

An αvβ6/αvβ8-targeting peptibody inhibits integrin-dependent TGFβ activation, enables tumor-selective cytotoxic delivery, and synergizes with PD-L1 immune checkpoint blockade.

Angelo Corti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.